Individualization of Custom Compounded Hormone Therapy in a Patient with Chemotherapy Induced Premature Ovarian Insufficiency and Impaired Liver Function – Case Report
Although the use of commercially manufactured hormone therapy (HT) to treat menopausal symptoms has declined during the past 12 years, the use of custom compounded HT seems to have increased. A 39-year-old woman with refractory anemia sustained premature ovarian insufficiency following allogeneic st...
Main Authors: | Damir Franić, Matjaž Sever, Andrej Janež, Maja Franić-Ivanišević, Mojca Jensterle |
---|---|
Format: | Article |
Language: | English |
Published: |
Sestre Milosrdnice University hospital, Institute of Clinical Medical Research
2019-01-01
|
Series: | Acta Clinica Croatica |
Subjects: | |
Online Access: | https://hrcak.srce.hr/file/322502 |
Similar Items
-
Genetic etiology of primary premature ovarian insufficiency
by: Maja Franić-Ivanišević, et al.
Published: (2016-01-01) -
Alzheimer’s Disease and Premature Ovarian Insufficiency
by: Svetlana Vujović, et al.
Published: (2023-04-01) -
Premature ovarian insufficiency – hormone replacement therapy and management of long-term consequences
by: Paulina Machura, et al.
Published: (2018-09-01) -
Mood disorders in women with premature ovarian insufficiency
by: Radosław Słopień
Published: (2018-09-01) -
Diagnostic challenges in suspected premature ovarian insufficiency
by: Eleni Armeni
Published: (2022-10-01)